No reports have yet examined the correlation between PD-L1 and MMR gene expressions in other benign tumors, so further studies are needed, especially regarding the association of their expressions in PAs as benign tumors and in pituitary carcinomas as malignant tumors. This evidence concerns the gene MRC1 and benign neoplasm.